WEARABLE DEVICES AND METHODS FOR MULTI-WAVELENGTH PHOTOBIOMODULATION FOR OCULAR TREATMENTS

• US 20160067087A1
• Filed: 09/09/2015
• Published: 03/10/2016
• Est. Priority Date: 09/09/2014
• Status: Abandoned Application

• Current Assignee: LumiThera, Inc.
• Original Assignee: LumiThera, Inc.
• Inventors: Tedford, Clark E, DeLapp, Scott, Bradley, Scott
• Application Number:
  US14/849,586
• Publication Number:
  US 20160067087A1
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61N 2005/0648 the light being directed to the eyes
• CPC Class Codes: A61N 2005/0659 infrared
• CPC Class Codes: A61N 2005/0662 Visible light
• CPC Class Codes: A61N 5/0613 Apparatus adapted for a specific treatment
• CPC Class Codes: A61N 5/0624 for eliminating microbes, germs, bacteria on or in the body
• CPC Class Codes: A61N 5/067 using laser light

Abstract

A wearable ophthalmic phototherapy device and associated treatment methods to expose an eye to selected multi-wavelengths of light to promote the healing of damaged or diseased eye tissue. The device includes a frame having a front piece and two earpieces extending from the front piece; and at least one light source producing a light beam having a therapeutic wavelength and disposed within or on the frame. The devices can include multiple different light sources to produce light with therapeutic wavelengths that differs from each other by at least 25 nm.

Claims

1. A wearable device for delivery of light therapy to ocular tissue of an eye of a patient, the device comprising:

a frame comprising a front piece and at least one affixation element attached to the front piece;

at least one first light source producing a first light beam having a first therapeutic wavelength and disposed within or on the frame; and

at least one second light source producing a second light beam having a second therapeutic wavelength and disposed within or on the frame, wherein the second therapeutic wavelength differs from the first therapeutic wavelength by at least 25 nm,

wherein at least a portion of the first and second light beams are directed toward the eye of the patient when the patient is wearing the wearable device.

2. The device of claim 1, further comprising at least one third light source producing a third light beam having a third therapeutic wavelength and disposed within or on the frame, wherein the third therapeutic wavelength differs from the first and second therapeutic wavelengths by at least 25 nm.

3. The device of claim 1, wherein the first wavelength is in a range from 800 to 900 nm and the second wavelength is in a range from 600 to 700 nm.

4. The device of claim 1, wherein the first wavelength is in a range from 800 to 900 nm and the second wavelength is in a range from 550 to 650 nm.

5. The device of claim 2, wherein the first wavelength is in a range from 800 to 900 nm, the second wavelength is in a range from 600 to 700 nm, and the third wavelength is in a range from 550 to 650 nm.

6. The device of claim 1, wherein the first and second light sources are disposed in one or more arrays on the front piece of the frame.

7. The device of claim 1, wherein the frame further defines two viewing ports in the front piece and the first and second light sources are disposed around the two viewing ports.

8. The device of claim 1, wherein the at least one affixation element comprises two earpieces and the frame further comprises at least one reflector disposed on the front piece, wherein the first and second light sources are disposed on the earpieces and configured and arranged to direct light toward the reflector, wherein the reflector is configured and arranged to redirect at least a portion of the light from the first and second light sources toward the eye of the patient when the patient wears the device.

9. The device of claim 8, wherein the reflector is partially transparent.

10. The device of claim 1, wherein the device further comprises

a spatial light modulator disposed within the frame and positioned to receive light from the first and second light sources and to modulate the light beam to generate a modulated light beam, and

a light directing element to receive the modulated light beam and direct at least a portion of the modulated light beam to the eye of the patient when the patient is wearing the device.

16. A method of providing light therapy to ocular tissue of a patient using the wearable device of claim 1, the method comprising:

placing the wearable device on the patient; and

directing light of at least one of the first therapeutic wavelength or the second therapeutic wavelength from device to the at least one eye of the patient to produce a therapeutic effect.

17. The method of claim 16, wherein directing light comprises directing light of at least one of the first therapeutic wavelength or the second therapeutic wavelength from device through an eyelid of the patient to the at least one eye of the patient to produce a therapeutic effect.

18. The method of claim 16, wherein directing light comprises directing light of both the first therapeutic wavelength or the second therapeutic wavelength from device through an eyelid of the patient to the at least one eye of the patient to produce a therapeutic effect.

19. The method of claim 18, wherein directing light of both the first therapeutic wavelength or the second therapeutic wavelength comprises sequentially directing light of both the first therapeutic wavelength or the second therapeutic wavelength from device through an eyelid of the patient to the at least one eye of the patient to produce a therapeutic effect.

20. The method of claim 18, wherein directing light of both the first therapeutic wavelength or the second therapeutic wavelength comprises simultaneously directing light of both the first therapeutic wavelength or the second therapeutic wavelength from device through an eyelid of the patient to the at least one eye of the patient to produce a therapeutic effect.

11. A wearable device for delivery of light therapy to ocular tissue of an eye of a patient, the device comprising:

a frame comprising a front piece and at least one affixation element attached to the front piece;

at least one light source producing a light beam having a therapeutic wavelength and disposed within the frame;

a spatial light modulator disposed within the frame and positioned to receive the light beam and to modulate the light beam to generate a modulated light beam; and

a light directing element to receive the modulated light beam and direct at least a portion of the modulated light beam to the eye of the patient when the patient is wearing the device.

12. The device of claim 11, wherein the light directing element is either a prism or a waveguide.

13. The device of claim 11, wherein the spatial light modulator is configured and arranged to modulate the light beam to form an image.

14. The device of claim 11, wherein the at least one light source comprises

at least one first light source producing a first light beam having a first therapeutic wavelength and disposed within the frame, and

at least one second light source producing a second light beam having a second therapeutic wavelength and disposed within the frame, wherein the second therapeutic wavelength differs from the first therapeutic wavelength by at least 25 nm.

15. The device of claim 14, wherein the at least one light source further comprises at least one third light source producing a third light beam having a third therapeutic wavelength and disposed within the frame, wherein the third therapeutic wavelength differs from the first and second therapeutic wavelengths by at least 25 nm.